Pre-IPO Concord Healthcare Group (PHIP Updates) - Some Points Worth the Attention
An acquisition stimulated the growth of Concord and brought its revenue scale to a new level. But concerns on endogenous growth capability and...
Pre-IPO Concord Healthcare Group - Business Challenges Are Greater than Expected
Concord’s profit margin is unsatisfactory due to inadequate operational management capability. Its future growth outlook is uncertain.The Company...
HSCI Index Rebalance Preview and Stock Connect: Potential Changes in September
There could be nearly 80 adds/deletes for the HSCI in September. That will trigger changes to the Southbound Stock Connect list and increase flows...
Concord Healthcare Pre-IPO Tearsheet
Concord Healthcare Group (CHG HK) is looking to raise at least US$100m in its upcoming Hong Kong IPO. The firm is an oncology health platform in...
Concord Healthcare Group (CHG HK) Pre-IPO: Accumulated Loss and Cash Burn Cloud Growth Prospects
Concord, a leading private oncology healthcare player in China, intends to list shares in Hong Kong. This loss making and cash burning company do...
No more insights